HBV-associated cryoglobulinemic vasculitis: Remission after antiviral therapy with entecavir

Kidney and Blood Pressure Research

Volumn 39, Issue 1, 2014, Pages 65-73

  Viganò, Mauro ^a   Martin, Paul ^b   Cappelletti, Mattia ^a   Fabrizi, Fabrizio ^b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b University School of Medicine   (United States)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Antiviral therapy; Cryoglobulinemia; Entecavir; Hepatitis B virus; Vasculitis

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ENTECAVIR; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; LEVOTHYROXINE; OMEPRAZOLE; ANTIVIRUS AGENT; GUANINE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTHRALGIA; ARTICLE; AUTOIMMUNE THYROIDITIS; CASE REPORT; CHINESE; CHRONIC HEPATITIS; CRYOGLOBULINEMIA; CRYOGLOBULINEMIC VASCULITIS; DISEASE DURATION; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GASTROESOPHAGEAL REFLUX; GLOMERULUS FILTRATION RATE; HEMOLYTIC ANEMIA; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HYPERTENSION; IMMUNOLOGICAL TOLERANCE; KIDNEY FUNCTION; LIMIT OF DETECTION; MEDICAL HISTORY; MONOTHERAPY; NEPHRITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; VASCULITIS; VIRUS LOAD; WEAKNESS; ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ANTIHYPERTENSIVE THERAPY; ASCITES; BLOOD CHEMISTRY; CHRONIC HEPATITIS B; COLONOSCOPY; DISEASE ASSOCIATION; ECHOGRAPHY; FATIGUE; FEVER; HEMATURIA; KIDNEY DISEASE; LABORATORY TEST; LIVER; LIVER DISEASE; MULTIPLE ORGAN FAILURE; PURPURA; SKIN DISEASE; URINALYSIS; ANALOGS AND DERIVATIVES; BLOOD; COMORBIDITY; COMPLICATION; DOSE RESPONSE; HEPATITIS B, CHRONIC; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; COMORBIDITY; CRYOGLOBULINEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GUANINE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; REMISSION INDUCTION; TRANSAMINASES; TREATMENT OUTCOME; VASCULITIS;

EID: 84903859753     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000355778     Document Type: Article

References (29)

1. Liver EAFTSOT: EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227-242
2. Cacoub B, Saadoun D, Bourliere M, Khiri H, Martineau A, Benhamou Y, Varastet M, Pol S, Thibault V, Rotily M, Halfon P: Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol 2005;43:764-770
3. Marzano A, Angelucci E, Andreone P, Brunetto M, Bruno R, Burra P, Caraceni P, Daniele B, Di Marco V, Fabrizi F, Fagiuoli S, Grossi P, Lampertico P, Meliconi R, Mangia A, Puoti M, Raimondo G, Smedile A, for the Italian Association for the Study of the Liver (AISF): Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis 2007;39:397-408
4. Filer A, Hughes A, Kane K, Mutimer D, Jobanputra P: Successful treatment of hepatitis B-associated vasculitis using lamivudine as the sole therapeutic agent. Rheumatology 2001;40:1064-1065
5. Stecevic V, Pevzner M, Gordon S: Successful treatment of hepatitis B-associated vasculitis with lamivudine. J Clin Gastroenterol 2003;36:451
6. Sawabe T, Uenotsuchi T, Imafuku S, Kohno H, Arima J: Remission of hepatitis B virus-related vasculitis with lamivudine. Ann Intern Med 2004;140:672-673
7. Cakir N, Pamuk O, Umit H, Midilli K: Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations. Intern Med 2006;45:1213-1215
8. Enomoto M, Makanishi T, Ishii M, Tamori A, Kawada N: Entecavir to treat hepatitis B-associated cryoglobulinemic vasculitis. Ann Intern Med 2008;149:912-913
9. Conca P, Riccio A, Tarantino G: Successful lamivudine monotherapy in an elderly patient suffering from HBV-related decompensated cirrhosis associated with widespread leukocytoclastic vasculitis. Int J Immunopathol 2009;22:531-535
10. Boglione L, D'Avolio A, Cariti G, Di Perri G: Telbivudine in the treatment of hepatitis B-associated cryoglobulinemia. J Clin Virol 2013;56:167-169
11. Yamazaki T, Akimoto T, Okuda K, Sugase T, Takeshima E, Numata A, Morishita Y, Iwazu Y, Yoshizawa H, Komada T, Iwazu K, Saito O, Takemoto F, Muto S, Kusano E: Purpura with ulcerative skin lesions and mixed cryoglobulinemia in a quiescent hepatitis B virus carrier. Intern Med 2014;53:115-119
12. Liao M, Chang M, Lin F, Tsai J, Chang Y, Tsau Y: Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy. Pediatrics 2011;128:e600-e604
13. Fabrizi F, Plaisier E, Saadoun D, Martin P, Messa P, Cacoub P: Hepatitis C virus infection, mixed cryoglobulinemia and kidney disease. Am J Kidney Dis 2013;61:623-637
14. Elewa U, Sandri A, Kim R, Fervenza F: Treatment of hepatitis B virus-associated nephropathy. Nephron Clin Pract 2011;119:c41-c49
15. Yang Y, Xiong Q, Zhao W, Zhong Y: Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy. Clin Res Hepatol Gastroenterol 2012;36:e89-e92
16. Fabrizi F, Viganò M, Banfi G, Martin P, Messa P, Lampertico P: HBV-related liver disease in renal insufficiency: successful therapy with entecavir. Int J Artif Organs 2011;34:1031-1035
17. La Civita L, Zignego A, Lombardini F, Monti M, Longombardo G, Pasero G, Ferri C: Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. J Rheumatol 1996;23:1641-1643
18. Lohr H, Goergen B, Weber W, Goddorz W, Meyer zum Buschenfelde K, Gerken G: Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: cellular immune reactions and response to interferon treatment. J Med Virol 1994;44:330-335
19. Pasquet F, Combarnous F, MacGregor B, Coppere B, Mausservey C, Ninert J, Hot A: Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report. J Med Case Rep 2012;6:39
20. Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, Puccini R, Michelassi C, Zignego A: Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004;33:355-374
21. Levo Y, Gorevic P, Kassab H, Zucker-Franklin D, Frankin E: Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977;296:1501-1504
22. Fiorini G, Bernasconi P, Sinico R, Chianese R, Pozzi F, D'Amico G: Increased frequency of antibodies to ubiquitous viruses in essential mixed cryoglobulinemia. Clin Exp Immunol 1986;64:65-70
23. Galli M: Cryoglobulinemia and serological markers of hepatitis viruses. Lancet 1991;338:758-759
24. Gorevic P, Kassab H, Levo Y: Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308
25. Zhang B, Wang J, Xu W, Wang L, Ni W: Fatal reactivation of occult hepatitis B virus infection after rituximab and chemotherapy in lymphoma: necessity of antiviral prophylaxis. Onkologie 2010;33:537-539
26. Evens A, Joyanovic B, Su Y, Raisch D, Ganger D, Belknap S, Dai M, Chiu B, Fintel B, Cheng Y, Chuang S, Lee M, Chen T, Lin S, Kuo C: Rituximab-associated hepatitis B virus (HBV) reactivation in lympho-proliferative diseases: meta-analysis and examination of FDA safety reports. Ann Oncol 2011;22:1170-1180
27. Koo Y, Tan D, Tan I, Tao M, Lim S: Hepatitis B virus reactivation in a patient with resolved hepatitis B virus infection receiving maintenance rituximab for malignant B-cell lymphoma. Ann Intern Med 2009;150:655- 656
28. Fabrizi F, Martin P, Elli A, Montagnino G, Banfi G, Passerini P, Campise R, Tarantino A, Ponticelli C: Hepatitis C virus infection and rituximab therapy after renal transplantation. Int J Artif Organs 2007;30:445-449
29. Matsue K, Kimura S, Takanashi Y, Iwama K, Fuijwara H, Yamakura M, Takeuchi M: Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma. Cancer 2010;116:4769-4776